9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer

NCT07314723 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Urothelial Carcinoma

Interventions

DRUG: 9MW2821
DRUG: Toripalimab Injection

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.